Medpace Holdings Retained Earnings (Accumulated Deficit) 2014-2024 | MEDP

Medpace Holdings retained earnings (accumulated deficit) from 2014 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
  • Medpace Holdings retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $0.066B, a 121.86% decline year-over-year.
  • Medpace Holdings retained earnings (accumulated deficit) for 2023 were $-0.222B, a 38.4% decline from 2022.
  • Medpace Holdings retained earnings (accumulated deficit) for 2022 were $-0.36B, a 253.13% decline from 2021.
  • Medpace Holdings retained earnings (accumulated deficit) for 2021 were $0.235B, a 103.93% increase from 2020.
Medpace Holdings Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2023 $-222
2022 $-360
2021 $235
2020 $115
2019 $68
2018 $-41
2017 $-120
2016 $-10
2015 $-23
2014 $-14
2013 $
Medpace Holdings Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-09-30 $66
2024-06-30 $-31
2024-03-31 $-119
2023-12-31 $-222
2023-09-30 $-300
2023-06-30 $-371
2023-03-31 $-408
2022-12-31 $-360
2022-09-30 $-380
2022-06-30 $-446
2022-03-31 $-121
2021-12-31 $235
2021-09-30 $185
2021-06-30 $142
2021-03-31 $159
2020-12-31 $115
2020-09-30 $112
2020-06-30 $70
2020-03-31 $54
2019-12-31 $68
2019-09-30 $38
2019-06-30 $14
2019-03-31 $-13
2018-12-31 $-41
2018-09-30 $-67
2018-06-30 $-87
2018-03-31 $-116
2017-12-31 $-120
2017-09-30 $-77
2017-06-30 $-18
2017-03-31 $-2
2016-12-31 $-10
2016-09-30 $-10
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2014-12-31 $-14
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $11.301B $1.886B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $98.658B 12.24
Cencora (COR) United States $49.082B 18.10
DiDi Global (DIDIY) China $23.427B 0.00
ICON (ICLR) Ireland $17.504B 15.59
Natera (NTRA) United States $16.570B 0.00
Viatris (VTRS) United States $15.624B 4.81
Avantor (AVTR) United States $15.178B 22.75
Revvity (RVTY) United States $14.682B 25.50
BioMerieux (BMXMF) France $13.087B 0.00
CochLear (CHEOY) Australia $12.998B 0.00
Solventum (SOLV) United States $12.357B 0.00
Doximity (DOCS) United States $11.372B 67.31
Charles River Laboratories (CRL) United States $11.285B 21.81
HealthEquity (HQY) United States $8.756B 47.52
Sonic Healthcare (SKHHY) Australia $8.590B 0.00
Bausch + Lomb (BLCO) Canada $7.202B 33.53
Life Times (LTH) United States $5.139B 34.01
Sotera Health (SHC) United States $4.509B 24.12
Organon (OGN) United States $4.144B 4.18
Surgery Partners (SGRY) United States $3.996B 44.27
BrightSpring Health Services (BTSG) United States $3.489B 74.22
PACS (PACS) United States $3.347B 0.00
Alignment Healthcare (ALHC) United States $2.580B 0.00
Concentras Parent (CON) United States $2.505B 0.00
Ardent Health Partners (ARDT) United States $2.471B 0.00
Premier (PINC) United States $2.314B 11.55
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $2.016B 0.00
GoodRx Holdings (GDRX) United States $1.856B 48.90
Teladoc Health (TDOC) United States $1.689B 0.00
Progyny (PGNY) United States $1.540B 27.08
Pediatrix Medical (MD) United States $1.371B 13.41
Establishment Labs Holdings (ESTA) $1.266B 0.00
CareDx (CDNA) United States $1.252B 0.00
AMN Healthcare Services Inc (AMN) United States $1.058B 7.16
Embecta (EMBC) United States $0.910B 6.07
Agilon Health (AGL) United States $0.890B 0.00
InnovAge Holding (INNV) United States $0.809B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.723B 0.00
Auna S.A (AUNA) Luxembourg $0.516B 0.00
Sonida Senior Living (SNDA) United States $0.459B 0.00
DocGo (DCGO) United States $0.411B 15.46
Enhabit (EHAB) United States $0.403B 34.83
COMPASS Pathways (CMPS) United Kingdom $0.363B 0.00
LifeMD (LFMD) United States $0.308B 0.00
Sera Prognostics (SERA) United States $0.248B 0.00
ModivCare (MODV) United States $0.231B 12.54
Beauty Health (SKIN) United States $0.218B 0.00
Biodesix (BDSX) United States $0.205B 0.00
Nutex Health (NUTX) United States $0.152B 0.00
MultiPlan (MPLN) United States $0.137B 0.00
Ascend Wellness Holdings (AAWH) United States $0.107B 0.00
So-Young (SY) China $0.088B 21.28
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.054B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.042B 1.10
Co-Diagnostics (CODX) United States $0.038B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00